Logo image of SMR

NUSCALE POWER CORP (SMR) Stock Fundamental Analysis

NYSE:SMR - New York Stock Exchange, Inc. - US67079K1007 - Common Stock - Currency: USD

39.35  -5.33 (-11.93%)

After market: 40.52 +1.17 (+2.97%)

Fundamental Rating

4

Taking everything into account, SMR scores 4 out of 10 in our fundamental rating. SMR was compared to 93 industry peers in the Electrical Equipment industry. No worries on liquidiy or solvency for SMR as it has an excellent financial health rating, but there are worries on the profitability. SMR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

SMR had negative earnings in the past year.
In the past year SMR has reported a negative cash flow from operations.
SMR had negative earnings in each of the past 5 years.
SMR had a negative operating cash flow in each of the past 5 years.
SMR Yearly Net Income VS EBIT VS OCF VS FCFSMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M -250M

1.2 Ratios

SMR has a Return On Assets (-21.69%) which is in line with its industry peers.
With a Return On Equity value of -19.04%, SMR perfoms like the industry average, outperforming 59.14% of the companies in the same industry.
Industry RankSector Rank
ROA -21.69%
ROE -19.04%
ROIC N/A
ROA(3y)-19.49%
ROA(5y)-66.14%
ROE(3y)-35.71%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SMR Yearly ROA, ROE, ROICSMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

SMR has a better Gross Margin (78.44%) than 98.92% of its industry peers.
In the last couple of years the Gross Margin of SMR has grown nicely.
The Profit Margin and Operating Margin are not available for SMR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.5%
GM growth 5Y45.02%
SMR Yearly Profit, Operating, Gross MarginsSMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

7

2. Health

2.1 Basic Checks

SMR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SMR has been increased compared to 1 year ago.
The number of shares outstanding for SMR has been increased compared to 5 years ago.
SMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SMR Yearly Shares OutstandingSMR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SMR Yearly Total Debt VS Total AssetsSMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

SMR has an Altman-Z score of -89.36. This is a bad value and indicates that SMR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -89.36, SMR is doing worse than 95.70% of the companies in the same industry.
SMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -89.36
ROIC/WACCN/A
WACC8.87%
SMR Yearly LT Debt VS Equity VS FCFSMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 6.23 indicates that SMR has no problem at all paying its short term obligations.
SMR has a better Current ratio (6.23) than 91.40% of its industry peers.
A Quick Ratio of 6.23 indicates that SMR has no problem at all paying its short term obligations.
The Quick ratio of SMR (6.23) is better than 92.47% of its industry peers.
Industry RankSector Rank
Current Ratio 6.23
Quick Ratio 6.23
SMR Yearly Current Assets VS Current LiabilitesSMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

SMR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.53%.
SMR shows a strong growth in Revenue. In the last year, the Revenue has grown by 62.41%.
SMR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 151.25% yearly.
EPS 1Y (TTM)-15.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.06%
Revenue 1Y (TTM)62.41%
Revenue growth 3Y134.85%
Revenue growth 5Y151.25%
Sales Q2Q%732.47%

3.2 Future

The Earnings Per Share is expected to grow by 15.03% on average over the next years. This is quite good.
The Revenue is expected to grow by 138.66% on average over the next years. This is a very strong growth
EPS Next Y71.87%
EPS Next 2Y31.96%
EPS Next 3Y21.22%
EPS Next 5Y15.03%
Revenue Next Year365.36%
Revenue Next 2Y247.52%
Revenue Next 3Y179.36%
Revenue Next 5Y138.66%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SMR Yearly Revenue VS EstimatesSMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
SMR Yearly EPS VS EstimatesSMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1

1

4. Valuation

4.1 Price/Earnings Ratio

SMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SMR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SMR Price Earnings VS Forward Price EarningsSMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SMR Per share dataSMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

SMR's earnings are expected to grow with 21.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.96%
EPS Next 3Y21.22%

0

5. Dividend

5.1 Amount

No dividends for SMR!.
Industry RankSector Rank
Dividend Yield N/A

NUSCALE POWER CORP

NYSE:SMR (8/8/2025, 8:06:58 PM)

After market: 40.52 +1.17 (+2.97%)

39.35

-5.33 (-11.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners59.35%
Inst Owner Change-0.47%
Ins Owners0.7%
Ins Owner Change0.16%
Market Cap11.19B
Analysts70.59
Price Target33.09 (-15.91%)
Short Float %22.78%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-237.23%
Min EPS beat(2)-501.86%
Max EPS beat(2)27.39%
EPS beat(4)1
Avg EPS beat(4)-172.35%
Min EPS beat(4)-501.86%
Max EPS beat(4)27.39%
EPS beat(8)2
Avg EPS beat(8)-101.67%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)602.3%
Min Revenue beat(2)210.83%
Max Revenue beat(2)993.77%
Revenue beat(4)2
Avg Revenue beat(4)258.36%
Min Revenue beat(4)-86.13%
Max Revenue beat(4)993.77%
Revenue beat(8)2
Avg Revenue beat(8)96.97%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19.34%
PT rev (3m)57.58%
EPS NQ rev (1m)-0.89%
EPS NQ rev (3m)33.53%
EPS NY rev (1m)-1.71%
EPS NY rev (3m)-38.78%
Revenue NQ rev (1m)-1.99%
Revenue NQ rev (3m)863.5%
Revenue NY rev (1m)0.41%
Revenue NY rev (3m)-13.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 228.19
P/FCF N/A
P/OCF N/A
P/B 15.9
P/tB 16.5
EV/EBITDA N/A
EPS(TTM)-1.19
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.17
BVpS2.48
TBVpS2.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.69%
ROE -19.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.44%
FCFM N/A
ROA(3y)-19.49%
ROA(5y)-66.14%
ROE(3y)-35.71%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.5%
GM growth 5Y45.02%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.85%
Cap/Sales 0.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.23
Quick Ratio 6.23
Altman-Z -89.36
F-Score5
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)52.05%
Cap/Depr(5y)82.9%
Cap/Sales(3y)9.14%
Cap/Sales(5y)136.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.06%
EPS Next Y71.87%
EPS Next 2Y31.96%
EPS Next 3Y21.22%
EPS Next 5Y15.03%
Revenue 1Y (TTM)62.41%
Revenue growth 3Y134.85%
Revenue growth 5Y151.25%
Sales Q2Q%732.47%
Revenue Next Year365.36%
Revenue Next 2Y247.52%
Revenue Next 3Y179.36%
Revenue Next 5Y138.66%
EBIT growth 1Y50.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year22.33%
EBIT Next 3Y10.73%
EBIT Next 5Y20.22%
FCF growth 1Y38.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.23%
OCF growth 3YN/A
OCF growth 5YN/A